Cargando…

Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels

BACKGROUND: Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neuro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kušnierová, Pavlína, Zeman, David, Hradílek, Pavel, Čábal, Martin, Zapletalová, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757126/
https://www.ncbi.nlm.nih.gov/pubmed/31199010
http://dx.doi.org/10.1002/jcla.22948
_version_ 1783453522479546368
author Kušnierová, Pavlína
Zeman, David
Hradílek, Pavel
Čábal, Martin
Zapletalová, Olga
author_facet Kušnierová, Pavlína
Zeman, David
Hradílek, Pavel
Čábal, Martin
Zapletalová, Olga
author_sort Kušnierová, Pavlína
collection PubMed
description BACKGROUND: Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neurofilament heavy chains (pNFHs). METHODS: Neurofilament concentrations were measured in CSF and S samples from 172 patients using three enzyme‐linked immunosorbent assays. Excel, Stata version 13, MedCal version 17.9.7., and NCSS 2007 software were used for the statistical analysis. RESULTS: There was a statistically significant correlation between the concentrations of CSF NFL and CSF pNFH (r (s) = 0.748; n = 89; P < 0.001), but Passing‐Bablok regression showed systematic deviation between the values obtained using the two assays. This indicates that the assays were not interchangeable. CSF pNFH and S pNFH concentrations showed low correlation. The kappa statistic showed moderate conformity between CSF pNFH and CSF NFL concentrations (κ = 0.556). CONCLUSIONS: The CSF NFL and CSF pNFH assays gave clinically consistent results that reflected the degree of axonal damage, independent of any particular neurological diagnosis. The S pNFH assays had a lower predictive value due to the low correlation coefficient and the kappa index of the CSF pNFH method.
format Online
Article
Text
id pubmed-6757126
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-67571262019-11-12 Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels Kušnierová, Pavlína Zeman, David Hradílek, Pavel Čábal, Martin Zapletalová, Olga J Clin Lab Anal Research Articles BACKGROUND: Neurofilaments are the major cytoskeletal components of neurons, and cell injury leads to their release into the surrounding area. The aim of this study was to compare the cerebrospinal fluid (CSF) and serum (S) concentrations of neurofilament light chains (NFLs) and phosphorylated neurofilament heavy chains (pNFHs). METHODS: Neurofilament concentrations were measured in CSF and S samples from 172 patients using three enzyme‐linked immunosorbent assays. Excel, Stata version 13, MedCal version 17.9.7., and NCSS 2007 software were used for the statistical analysis. RESULTS: There was a statistically significant correlation between the concentrations of CSF NFL and CSF pNFH (r (s) = 0.748; n = 89; P < 0.001), but Passing‐Bablok regression showed systematic deviation between the values obtained using the two assays. This indicates that the assays were not interchangeable. CSF pNFH and S pNFH concentrations showed low correlation. The kappa statistic showed moderate conformity between CSF pNFH and CSF NFL concentrations (κ = 0.556). CONCLUSIONS: The CSF NFL and CSF pNFH assays gave clinically consistent results that reflected the degree of axonal damage, independent of any particular neurological diagnosis. The S pNFH assays had a lower predictive value due to the low correlation coefficient and the kappa index of the CSF pNFH method. John Wiley and Sons Inc. 2019-06-14 /pmc/articles/PMC6757126/ /pubmed/31199010 http://dx.doi.org/10.1002/jcla.22948 Text en © 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Kušnierová, Pavlína
Zeman, David
Hradílek, Pavel
Čábal, Martin
Zapletalová, Olga
Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title_full Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title_fullStr Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title_full_unstemmed Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title_short Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels
title_sort neurofilament levels in patients with neurological diseases: a comparison of neurofilament light and heavy chain levels
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757126/
https://www.ncbi.nlm.nih.gov/pubmed/31199010
http://dx.doi.org/10.1002/jcla.22948
work_keys_str_mv AT kusnierovapavlina neurofilamentlevelsinpatientswithneurologicaldiseasesacomparisonofneurofilamentlightandheavychainlevels
AT zemandavid neurofilamentlevelsinpatientswithneurologicaldiseasesacomparisonofneurofilamentlightandheavychainlevels
AT hradilekpavel neurofilamentlevelsinpatientswithneurologicaldiseasesacomparisonofneurofilamentlightandheavychainlevels
AT cabalmartin neurofilamentlevelsinpatientswithneurologicaldiseasesacomparisonofneurofilamentlightandheavychainlevels
AT zapletalovaolga neurofilamentlevelsinpatientswithneurologicaldiseasesacomparisonofneurofilamentlightandheavychainlevels